Status:
UNKNOWN
Assessment Of Long Noncoding RNA CCAT1 In Colorectal Cancer Patients
Lead Sponsor:
Assiut University
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18-80 years
Brief Summary
1. Evaluate the diagnostic value of long noncoding RNA (CCAT1) expression by RT-PCR in peripheral blood in colorectal cancer patients versus normal healthy control personal. 2. Evaluate the clinical u...
Detailed Description
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the fourth leading cause of cancer mortality worldwide. Colorectal cancer is the 7th commonest cancer in Egypt, representing 3.4...
Eligibility Criteria
Inclusion
- Patients newly diagnosed with colorectal cancer
Exclusion
- 1\. Patients with colorectal cancer that had been received chemotherapy, radiotherapy or surgical treatment.
- 2\. History of non-precancerous benign colorectal diseases (Irritable bowel syndrome, colitis, appendicitis, diverticulitis, paralytic ileus \& intussusception).
- 3\. History of benign or malignant tumors in other organs.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04269746
Start Date
December 1 2020
End Date
September 1 2021
Last Update
July 8 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.